Plakous Therapeutics, Inc.
Winston-Salem, NC
- UEI
- EWBAJV2C51K4
- CAGE
- 7MED4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 755 Highland Oaks Dr #103, Winston-Salem, NC 27103, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a human placental extract for the prevention of necrotizing enterocolitis in premature babies | National Institute of Child Health and Human Development (NIH) | $9,214,792 |
SBA capabilities narrative
PLAKOUS THERAPEUTICS is a human biologics company pioneering in situ restorative and regenerative healing with allografts which contain and deliver the cytokines and growth factors remaining in the human placenta after the delivery.
Quick answers
Is Plakous Therapeutics, Inc. registered in SAM.gov?
Yes. Plakous Therapeutics, Inc.'s SAM.gov registration is active through January 5, 2027.
What is Plakous Therapeutics, Inc.'s most recent federal award?
Plakous Therapeutics, Inc.'s most recent federal grant award is Development of a human placental extract for the prevention of necrotizing enterocolitis in premature babies (R44HD100243), from National Institute of Child Health and Human Development (NIH), on July 2, 2020.
On GovTribe
See Plakous Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors